Overall Status

Completed (144)

Unknown status (25)

Recruiting (22)

Terminated (15)

Not yet recruiting (14)

Withdrawn (6)

Active, not recruiting (3)

Suspended (1)

Phase

phase 2 (45)

phase 1 (41)

n/a (39)

phase 3 (32)

phase 4 (22)

phase 1/phase 2 (10)

phase 2/phase 3 (5)

early phase 1 (3)

Study Documents

Individual Participant Data Set (3)

Study Protocol (2)

Study summary, -design,-demographics, -mechanistic assays, -files et al. (2)

Study overview & protocol synopsis, -navigator, -schedule of assessments, -data&reports, -specimens, etc. (1)

Study summary, -schematic, -design, -adverse event(s),-medications,-demographics, - lab tests, -study files (1)

Funder Type

Other (127)

NIH (52)

Industry (51)

Study Type

Interventional (197)

Observational (32)

Observational [Patient Registry] (1)

Ganciclovir

Showing 226 - 230 of 230

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cytomegalovirus Retinitis, HIV Trial in New York (Valganciclovir)

Completed

Cytomegalovirus Retinitis
HIV Infections

Valganciclovir

New York, New York

Cornell AIDS Clinical Trials Unit

Jun 23, 2005

Cytomegalovirus Retinitis, HIV Trial in Puerto Rico, United States (Valganciclovir)

Unknown status

Cytomegalovirus Retinitis
HIV Infections

Valganciclovir

Beverly Hills, California
+8 more

Jun 23, 2005

Cytomegalovirus Retinitis, HIV Trial in Boston, Galveston (Sevirumab)

Completed

Cytomegalovirus Retinitis
HIV Infections

Sevirumab

Boston, Massachusetts
+1 more

Jun 23, 2005

Cytomegalovirus Retinitis, HIV Trial in United States (Fomivirsen sodium)

Completed

Cytomegalovirus Retinitis
HIV Infections

Fomivirsen sodium

Irvine, California
+24 more

Jun 23, 2005

HIV Trial in United States (Zalcitabine)

Completed

HIV Infections

Zalcitabine

San Francisco, California
+8 more

Jun 23, 2005